Overview

Adarza BioSystems, Inc. is a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid.

Founded in 2008, Adarza has developed a highly sensitive label-free diagnostic platform capable of measuring 100s more individual proteins than the best multiplex immunoassays available today.

The Arrayed Imaging Reflectometry (AIR™) is a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid. Adarza delivers industry leading precision, accuracy, and robustness enabling highly multiplexed protein detection with high sensitivity and specificity. The company’s unique technology is flexible, data-rich, and easy to use, providing the only solution that spans the entire companion diagnostic life cycle from discovery to clinic, in both high-throughput core facilities as well as point of care (POC). Much like the first gene-chips enabled multiplexed genomics analysis, Adarza’s first-to-market high-multiplex and sensitivity antibody chips will fundamentally disrupt the field of proteomics research.

Adarza is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at University of Rochester by Dr. Benjamin Miller, Adarza’s scientific founder.

Our Team

Adarza Biosystems, Inc. brings the best business, scientific and operations minds together as a dynamic, forward thinking human-centered force dedicated to the transformative promise of science.

Learn More

Investors

Meet the global leaders in life science tools and immunodiagnostics that believe in Adarza’s distruptive technology platform.

Learn More

Partnering

Learn how to partner with us to enable your research with AIR Technology.

Learn More

Timeline

A history of innovation.

Learn More